Biotechnology
TheracosBio is a pharmaceutical company located in Marlborough, Massachusetts. TheracosBio discovers, develops and commercializes medicines for important diseases. TheracosBio believes that affordable medications for prevalent conditions may lead to more rapid advances in public health. TheracosBio has gained FDA approval of its proprietary medicine Brenzavvy™ (bexagliflozin), an oral sodium-glucose cotransporter 2 (SGLT2) inhibitor. BRENZAVVY is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes. .